-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Pts0OQn9xnW2+lSaQAlTFV1Wlr44IxMwOOM0Kom+AVA0osuE980qyemYMMPFnuto +wt8xMlbq/APVNSo04a85Q== 0000914317-01-000029.txt : 20010123 0000914317-01-000029.hdr.sgml : 20010123 ACCESSION NUMBER: 0000914317-01-000029 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20010110 FILED AS OF DATE: 20010110 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MERIDIAN MEDICAL TECHNOLOGIES INC CENTRAL INDEX KEY: 0000095676 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 520898764 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: 4 SEC ACT: SEC FILE NUMBER: 000-05958 FILM NUMBER: 1506318 BUSINESS ADDRESS: STREET 1: 10240 OLD COLUMBIA RD STREET 2: STE 100 CITY: COLUMBIA STATE: MD ZIP: 21046 BUSINESS PHONE: 4103096830 MAIL ADDRESS: STREET 1: 10240 OLD COLUMBIA ROAD CITY: COLUMBIA STATE: DE ZIP: 21046- FORMER COMPANY: FORMER CONFORMED NAME: SURVIVAL TECHNOLOGY INC DATE OF NAME CHANGE: 19920703 COMPANY DATA: COMPANY CONFORMED NAME: COMMONWEALTH BIOVENTURES V L P CENTRAL INDEX KEY: 0000910176 STANDARD INDUSTRIAL CLASSIFICATION: [] OWNER IRS NUMBER: 043188204 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 BUSINESS ADDRESS: STREET 1: 4 MILK ST CITY: PORTLAND STATE: ME ZIP: 04101 BUSINESS PHONE: 2077800904 MAIL ADDRESS: STREET 1: 4 MILK ST CITY: PORTLAND STATE: ME ZIP: 04101 4 1 0001.txt FORM 4 U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 ================================================================================ 1. Name and Address of Reporting Person* Commonwealth BioVentures V Limited Partnership - -------------------------------------------------------------------------------- (Last) (First) (Middle) 4 Milk Street - -------------------------------------------------------------------------------- (Street) Portland ME 04101 - -------------------------------------------------------------------------------- (City) (State) (Zip) ================================================================================ 2. Issuer Name and Ticker of Trading Symbol Meridian Medical Technologies, Inc. MTEC ================================================================================ 3. IRS or Social Security Number of Reporting Person (Voluntary) ================================================================================ 4. Statement for Month/Year December 2000 ================================================================================ 5. If Amendment, Date of Original (Month/Year) ================================================================================ 6. Relationship of Reporting Person to Issuer (Check all applicable) [ ] Director [X] 10% Owner [ ] Officer (give title below) [ ] Other (specify below) ================================================================================ 7. Individual or Joint/Group filing (Check Appropriate Line) [X] Form filed by One Reporting Person [ ] Form filed by More Than One Reporting Person ================================================================================ *If the form is filed by more than one person, see Instruction 4(b)(v)
==================================================================================================================================== TABLE I -- NON-DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENFICIALLY OWNED ==================================================================================================================================== 1. Title of Security (Instr. 3) 2. Transaction Date 3. Transaction Code 4. Securities Acquired (A) (Month/Day/Year) (Instr. 8) or Disposed of (D) (Instr. 3, 4 and 5) ------------------- ------------------- -------------------------- (A) or Code V Amount (D) Price - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 12/01/00 S 10,000 D $9.250 - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 12/01/00 S 1,000 D $10.375 - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------
==================================================================================================================================== TABLE I -- NON-DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENFICIALLY OWNED -- Continued ==================================================================================================================================== 1. Title of Security (Instr. 3) 5. Amount of Securities 6. Ownership Form: 7. Nature of Indirect Beneficially Owned Direct (D) or Beneficial at End of Month Indirect (I) Ownership (Instr. 3 and 4) (Instr. 4) (Instr. 4) - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 146,551 D - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ ====================================================================================================================================
==================================================================================================================================== TABLE II -- DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY OWNED (E.G., PUTS, CALLS, WARRANTS, OPTION, CONVERTIBLE SECURITIES) ==================================================================================================================================== 1. Title of Derivative Security 2. Conversion 3. Transaction Date 4. Transaction Code 5. Number of Derivative (Instr. 3) Or Exercise (Month/Day/Year) (Instr. 8) Securities Acquired (A) Price of or Disposed of (D) Derivative (Instr. 3, 4, and 5) Security ------------- ------------------- -------------------- --------------------------- Code V (A) (D) - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------
==================================================================================================================================== TABLE II -- DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY OWNED (E.G., PUTS, CALLS, WARRANTS, OPTION, CONVERTIBLE SECURITIES) -- Continued ==================================================================================================================================== 1. Title of Derivative Security 6. Date 7. Title and 8. Price of (Instr. 3) Exercisable Amount of Derivavtive and Underlying Security Expiration Securities (Instr. 5) Date (Month/ (Instr. 3 Day/Year) and 4) -------------------- ---------------------------- -------------- Date Expira- Amount or Exer- tion Number cisable Date Title of Shares - ------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------
==================================================================================================================================== TABLE II -- DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY OWNED (E.G., PUTS, CALLS, WARRANTS, OPTION, CONVERTIBLE SECURITIES) -- Continued ==================================================================================================================================== 1. Title of Derivative Security 9. Number of Derivative 10. Ownership Form of 11. Nature of Indirect (Instr. 3) Securities Beneficially Derivative Security: Beneficial Owned at End of Month Direct (D) or Ownership (Instr. 4) Indirect (I) (Instr. 4) (Instr. 4) - ------------------------------------------------------------------------------------------------------------------------------------ ====================================================================================================================================
Explanation of Responses: /s/Commonwealth BioVentures V Limited Partnership By: BioVentures Limted Partnership, its general partner By: Commonwealth Bioventures, Inc., its general partner By: Robert G. Foster, President 01/10/2001 - --------------------------------------------------- -------------- **Signature of Reporting Person Date **Intentional misstatements or ommissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number. -----END PRIVACY-ENHANCED MESSAGE-----